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Abstract
Background: Quantification and visualisation of left ventricular (LV) blood flow is afforded by three-dimensional, time
resolved phase contrast cardiovascular magnetic resonance (CMR 4D flow). However, few data exist upon the
repeatability and variability of these parameters in a healthy population. We aimed to assess the repeatability and
variability over time of LV 4D CMR flow measurements.
Methods: Forty five controls underwent CMR 4D flow data acquisition. Of these, 10 underwent a second scan within
the same visit (scan-rescan), 25 returned for a second visit (interval scan; median interval 52 days, IQR 28–57 days). The
LV-end diastolic volume (EDV) was divided into four flow components: 1) Direct flow: inflow that passes directly to
ejection; 2) Retained inflow: inflow that enters and resides within the LV; 3) Delayed ejection flow: starts within the LV and
is ejected and 4) Residual volume: blood that resides within the LV for > 2 cardiac cycles. Each flow components’ volume
was related to the EDV (volume-ratio). The kinetic energy at end-diastole (ED) was measured and divided by the
components’ volume.
Results: The dominant flow component in all 45 controls was the direct flow (volume ratio 38 ± 4%) followed by the
residual volume (30 ± 4%), then delayed ejection flow (16 ± 3%) and retained inflow (16 ± 4%). The kinetic energy at ED
for each component was direct flow (7.8 ± 3.0 microJ/ml), retained inflow (4.1 ± 2.0 microJ/ml), delayed ejection flow (6.
3 ± 2.3 microJ/ml) and the residual volume (1.2 ± 0.5 microJ/ml). The coefficients of variation for the scan-rescan ranged
from 2.5%–9.2% for the flow components’ volume ratio and between 13.5%–17.7% for the kinetic energy. The interval
scan results showed higher coefficients of variation with values from 6.2–16.1% for the flow components’ volume ratio
and 16.9–29.0% for the kinetic energy of the flow components.
Conclusion: LV flow components’ volume and their associated kinetic energy values are repeatable and stable within
a population over time. However, the variability of these measurements in individuals over time is greater than can be
attributed to sources of error in the data acquisition and analysis, suggesting that additional physiological factors may
influence LV flow measurements.
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Background
The main purpose of the cardiovascular system is to drive,
control and maintain blood flow through the heart and
vessels [1]. Insights into intra-cardiac blood flow are now
afforded by the use of retrospectively electrocardiogram
(ECG) gated, three-dimensional (3D), time resolved flow
encoded cardiovascular magnetic resonance (CMR) (3D +
time = 4D flow) [2–6]. The 4D flow within the left
ventricle (LV) can be separated into four functional flow
components and the kinetic energy (KE) of the blood
throughout the cardiac cycle can be quantified [3, 7, 8]. In
healthy hearts these functional flow components have spe-
cific routes and energetics that may represent important
aspects of normal ventricular function [9]. Typically a
third of the inflow to the LV passes directly through to the
aorta in healthy hearts allowing a preservation of LV
inflow KE, which may assist with an efficient systolic ejec-
tion phase. Alterations in LV blood flow components have
been found in patients with early compensated dilated car-
diomyopathy, where a substantial proportion of the inflow
is retained within the LV and there is an associated
decrease in preservation of the LV inflow KE [8]. These
findings suggest that the volume and KE of the 4D flow
components may be sensitive biomarkers for the early
detection of cardiac pathology. 4D flow also provides a
potential future tool for the evaluation of therapeutic
interventions [10]. However the use of 4D flow compo-
nents for early diagnosis and monitoring of changes in
individual patients requires an understanding of the intra-
subject repeatability of the measures and the variability of
these parameters over time.
To date, studies reporting healthy control data have
enrolled small numbers, typically 6–17 participants with
data acquired at a single time point [3–5, 8] and none
have assessed the stability of LV 4D flow components over
time. Thus, this study aims to understand the stability of
the volume and KE profiles of LV flow components in
healthy participants. In order to achieve this we first
assessed the repeatability of the 4D flow data acquisition,
post-processing and analysis in order to understand the
error associated with the technique. Subsequently we
determined how these components change over time by
repeating a data acquisition after a period of a few weeks.
Methods
Study population
Forty five healthy subjects were prospectively recruited
specifically for the aims of this study. All participants
had no contraindication to CMR scanning, no history of
cardiac disease, nor symptoms of cardiac disease. This
study was approved by the local research ethics commit-
tee and written informed consent was obtained from
each participant.
Ten of the participants underwent two 4D flow data
acquisitions within the same study visit to assess ‘scan-
rescan’ repeatability. Between each data acquisition the
participant was removed completely from the scanner so
each data set was acquired with the same potential real-
life sources of variance, including subtle changes in sub-
ject positioning in the CMR system. Twenty five of the
participants returned for a second ‘interval’ 4D flow data
acquisition at least 10 days later (52 ± IQR 28–57 days).
The participants in the scan-rescan and interval groups
were different as this study was conducted in two
phases. Additional file 1: Table S1 shows that the two
groups were similar for cardiac function measurements.
Anthropometric measurements
Height and weight were recorded and body mass index
(BMI) calculated. Blood pressure was recorded as an aver-
age of 3 supine measurements taken over 10 min (DINA-
MAP-1846-SX, Critikon Corporation; General Electric
Healthcare, Waukesha, Wisconsin, USA). Heart rate was
recorded at the time of the short axis stack acquisition.
Cardiovascular magnetic resonance protocol
Each participant underwent CMR imaging on a 3 Tesla
system (Trio, Siemens Healthineers Erlangen, Germany)
using a 32 channel cardiac coil. All images were ECG-
gated. Images for LV volumes were acquired using
retrospectively gated balanced steady-state free preces-
sion (bSSFP) cine sequences scan parameters were echo
time 1.5 ms, repetition time 3 ms and flip angle 50°.
Slice thickness was 8 mm with contiguous slice position
for the short axis stack. Each cine slice was acquired
during a single breath hold, as a free breathing method
was not available, this protocol allowed shorter breath
holds (which will be helpful when this technique is
utilised in patients), and easier repetition if any mis-
triggering or breathing artefact occurred during data
acquisition. Cine images were analysed using cmr42
(Circle Cardiovascular Imaging Inc., Calgary, Canada) as
previously described [11].
4D flow data acquisitions were acquired during free
breathing, using a retrospectively ECG triggered, respira-
tory navigator gated three dimensional (3D), three direc-
tional, time resolved phase contrast CMR sequence with
data measured over many cardiac cycles. The echo time
was 2.75 ms with a repetition time of 4.3 ms and temporal
resolution of 52 ms. The flip angle was 7°, read field of
view 390 mm and voxel size 3x3x3 mm3. The velocity
encoding was 100 cm/s. The field-of-view (FOV) was
sagittal and adjusted for each subject to fully encompass
the whole heart. The data acquisition times were between
15 and 20 min. While the data are presented as a single
cardiac cycle they capture the complete cardiac cycle which
means they can be used to form a closed loop where the
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first and last frame are also consecutive frames. For illustra-
tion: if the 4D flow loop is concatenated after itself (doub-
ling the number of time frames) the data will appear
continuous and to have captured two cardiac cycles.
Post processing and data analysis
Background phase offsets were corrected with a third-
order polynomial fit. Data quality control steps were
applied as previously described [3] using automated cus-
tomised Matlab software (The Mathworks Inc., Natick,
Massachusetts, USA). Velocity data was converted into a
file format compatible with commercially available visu-
alisation software (EnSight, CEI Inc., Research Triangle
Park, North Carolina, USA).
All data sets were analysed using a method previously
described by Eriksson et al. [3, 5]. The LV endocardium
was manually segmented from short-axis images at end
diastole (ED) and end systole (ES), using freely available
software (Segment, version 1.9 R2842) [12]. The ED and
ES timeframes were determined by visual inspection of
the open or closed positions of the aortic and mitral
valves and the LV size in the long and short axis im-
ages. The segmentation at ED is resampled to give a
volume with isotropic voxels equal to the size of the
flow data voxels. A pathline is emitted from the centre
of each voxel included in the LV segmentation. Path-
lines are created forwards and backwards in time until
the preceding or subsequent ES, respectively. A path-
line is a probabilistic path a finite volume of blood
takes through space as a function of time. Combined
these forward and backward pathlines represent the
entire LV end diastolic volume (EDV) tracked over one
complete cardiac cycle. The positions of all pathlines at
the time of ES relative to the LV cavity, as defined by
the segmentation at ES, are then used to divide them
into four functional flow components: direct flow,
retained inflow, delayed ejection flow and residual vol-
ume as described previously [3, 5, 8]. Direct flow is de-
fined as blood that enters and exits the LV in the
analysed cardiac cycle, retained inflow enters the LV
but does not exit during the same cardiac cycle, whilst
delayed ejection flow starts within the LV but exits dur-
ing the analysed cardiac cycle and residual volume is
the component that resides within the LV for at least 2
cardiac cycles, these are illustrated in Fig. 1a. Accuracy
of this quantification was evaluated by comparing the
LV inflow components (direct flow and retained inflow)
to the LV outflow components (direct flow and delayed
ejection flow), any data sets with > 10% difference
would have been excluded from further analysis for
quality control, however no datasets met this criteria so
all acquired datasets were included in the further
analysis.
The KE of these flow components can be calculated
throughout the cardiac cycle by utilising KE
= ½▪ρblood▪Vpathline▪v
2
pathline, where ρblood is blood density,
V pathline the volume of blood that a pathline is emitted
from, equal to one voxel, and v pathline the velocity of the
pathline at a given time point. The KE for each compo-
nent is the sum of all pathlines in the group. The KE
values were calculated over the cardiac cycle and re-
ported at ED, as the KE values at this time-point reflect
the preservation of the inflowing KE prior to the rapid
ejection of blood during systole. The KE at ED for each
component was then divided by the components volume
to give a KE per millilitre value, therefore removing any
variation due to LV cavity size.
Intra- and inter-observer variability
Intra-observer variability was determined by an operator
experienced in CMR who conducted two blinded assess-
ments of 10 randomly selected data sets, with each assess-
ment separated by more than one month. Inter-observer
variability was conducted independently by a second
observer experienced in CMR with the same 10 datasets.
Statistical analysis
Statistical analysis was performed with SPSS (version
22, International Business Machines, Armonk, New
York, USA). Data were tested for normality using
the D’Agostino and Pearson omnibus normality test
and values are presented as mean ± standard devia-
tions, unless otherwise specified. For 2 group com-
parisons the Student’s t test was used for normally
distributed data or Mann Whitney U test was used
for non-normally distributed data. Repeated measures
ANOVA with post hoc Tukeys’s multiple comparisons test
or Friedman test with post hoc Dunn’s multiple compari-
son tests were performed for normally and non-normally
distributed multiple groups respectively. P values < 0.05
were considered significant. Correlation was assessed
using the Pearson or Spearman method as appropriate.
Repeatability was assessed by consideration of the absolute
difference between the results obtained from scan 1 and 2
for each subject. The coefficient of variance (CoV) was
calculated for each subject, using the root mean square
method [13]. The average CoV for a group for scan-rescan
and interval scan repeatability was calculated by summing
the squares of the variance for each subject, then taking
the mean of the CoVs for all subjects and then square
rooting this value. Mann Whitney tests were conducted to
compare the CoV for the scan-rescan results to the CoV
for the interval scan results. Bland-Altman plots [14] were
used to display the differences between the paired
datasets.
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Results
Participant characteristics
Forty-five participants were recruited; mean age 54 ±
14 years (range 24–75 years) and 27 (59%) male. Demo-
graphic, anthropometric and routine CMR measurements
are shown in Table 1. All LV volumes were within the nor-
mal range [15] and the mean ejection fraction was 66 ± 4%.
4D flow components’ volume and kinetic energy
All 80 data acquisitions passed data quality checks, with
no significant difference in inflow versus ejected volume
(inflow 82 ± 21 ml, outflow 81 ± 22 ml, P = 0.57).
Figure 1a demonstrates the visualised flow components,
whilst Fig. 1b shows the average proportion of the 4 flow
components as a percentage of the EDV for all 45 partici-
pants. The average contribution of each flow component,
from largest to smallest, was: direct flow (38 ± 4%),
residual volume (30 ± 4%), retained inflow (16 ± 4%) and
delayed ejection flow (16 ± 3%). The results in Table 2 of
repeated measures ANOVA comparisons with Tukey
post-hoc testing demonstrate that the 4 flow components
volumes were all significantly different to each other
except for the retained inflow and delayed ejection flow.
The kinetic energy at ED in proportion to blood
volume for each flow component is shown in Fig. 1c.
The ED kinetic energy of each flow component, ordered
from largest to smallest was: direct flow (7.8 ± 3.0
microJ/ml), delayed ejection flow (6.3 ± 2.3 microJ/ml),
retained inflow (4.1 ± 2.0 microJ/ml) and residual volume
(1.2 ± 0.5 microJ/ml). The mean KE at ED was statisti-
cally significantly different between all flow components,
as found by comparison with Friedman test with post
hoc Dunn’s testing demonstrated in Table 2.
Intra and inter-observer variability
The results from the intra and inter-observer variability for
the flow components as a percentage of the EDV are shown
in Table 3. The coefficients of variation for the different
flow components were low and similar for both intra and
inter-observer results (range intra-observer 3.6–6.1%, vs
Fig. 1 Visualisation and quantification of LV blood flow components’ volume and kinetic energy values at end-diastole for all 45 participants. a
Flow visualisation throughout the cardiac cycle from left to right panel; early diastole, diastasis, atrial contraction and systolic ejection. LA, left
atrium. b Flow components by percentage of EDV. c Kinetic energy at end-diastole related to blood volume of the 4 flow components
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inter-observer 2.6–5.7%), suggesting good intra and inter-
observer variability.
Scan-rescan repeatability
Ten subjects underwent 2 data acquisitions within the
same study visit; Bland-Altman plots are shown in Fig. 2a
for the relative volume and kinetic energy value at ED for
each flow component. The observed mean difference
values and coefficient of variation (CoV) for these results
are summarised in Table 4. The flow component with the
lowest CoV was the direct flow (2.5%), whilst the most
variable flow component as a percentage of the EDV was
the delayed ejection flow (CoV 9.2%). The kinetic energy
values had higher coefficients of variation than those for
the percentage of each flow component; with a range of
13.5% for direct flow to 17.7% for delayed ejection flow.
Interval scans: Evaluation of variability and physiological
variability
A total of 25 participants returned for a second scan
after a median interval period of 52 days (IQR 28–
57 days). The average proportion of each flow compo-
nent as a percentage of the EDV did not differ signifi-
cantly between visits, nor did the mean kinetic energy
per millilitre at ED, as shown in Fig. 3. Figure 2b shows
the Bland-Altman plots for the flow components’
volume and kinetic energy values; observed mean differ-
ence values and coefficients of variation are provided in
Table 3. The 95% confidence intervals and CoV for each
parameter measured are increased compared to those
for the 10 scan-rescan datasets. As before the most
stable flow parameter by percentage of EDV was the dir-
ect flow (CoV 6.2%) and the most variable component
was the retained inflow (CoV 16.1%). The coefficients of
variation for the KE values were again higher than those
for the flow components as a percentage of EDV. The
least variable parameter was the direct flow kinetic
energy (CoV 16.9%), whilst the residual volume was the
most variable with a CoV of 29.0%.
In order to understand whether the variability seen in
each flow component volume and associated KE value,
between the interval scans, was related to physiological
parameters the changes in these results were correlated
against each other. The mean difference between scan 1
and 2 was calculated for heart rate (2 ± 7 beats/min), LV
EDV (3 ± 11 ml), stroke volume (1 ± 9 ml), LV ejection
fraction (EF) (1 ± 3%) and cardiac output (10 ± 90 ml).
There were no correlations seen between any of the flow
component percentages or KE changes with the change in
stroke volume, LV EDV or cardiac output. The change in
the KE of the delayed ejection flow correlated weakly to the
change in EF (r = 0.435, P = 0.03). Correlations were seen
between the change in heart rate and the breakdown of
flow components as a percentage of the EDV (direct flow r
Table 2 Multiple comparisons following repeated measures
ANOVA for flow components as a percentage of EDV and
Friedman test for KE at ED
Mean ± SD Retained
inflow
(P value)
Delayed
ejection flow
(P value)
Residual
volume
(P value)
Multiple comparisons for volume, % EDV
Direct flow, % EDV 38 ± 4 < 0.001 < 0.001 < 0.001
Retained inflow, % EDV 16 ± 4 ̶ 0.7534 < 0.001
Delayed ejection flow, % EDV 16 ± 3 0.7534 ̶ < 0.001
Residual volume, % EDV 30 ± 4 < 0.001 < 0.001 ̶
Multiple comparisons
for KE at ED, μJ/ml
Direct flow, μJ/ml 7.8 ± 3.0 < 0.001 0.0256 < 0.001
Retained inflow, μJ/ml 4.1 ± 2.0 ̶ 0.0049 < 0.001
Delayed ejection flow, μJ/ml 6.3 ± 2.3 0.0049 ̶ < 0.001
Residual volume, μJ/ml 1.2 ± 0.5 < 0.001 < 0.001 ̶
SD indicates Standard deviation, EDV End-diastolic volume, KE Kinetic energy
Table 3 Intra and Inter-observer variability
Intra-observer
(Investigator 1)
Inter-observer
(Investigator 2)
Analysis 1.1 Analysis 1.2 CoV Analysis 2 CoV
Direct flow, % EDV 38 ± 4 37 ± 5 3.9 36 ± 5 5.7
Retained inflow, % EDV 14 ± 3 15 ± 3 3.6 15 ± 3 2.6
Delayed ejection flow, % EDV 17 ± 3 17 ± 3 6.1 18 ± 3 4.8
Residual volume, % EDV 31 ± 3 30 ± 3 3.5 31 ± 4 5.0
Ejection fraction, % 70 ± 3 69 ± 3 4.0 67 ± 4 4.1
EDV, ml 162 ± 46 166 ± 44 4.3 154 ± 40 5.8
ESV, ml 50 ± 16 51 ± 17 5.7 51 ± 16 5.6
CoV Coefficient of variation, EDV End diastolic volume, ESV End systolic volume
Table 1 Demographic, anthropometric and routine CMR
measurements
Controls
N = 45
Age, years 54 ± 14 (range 24–75)
Male, % 59
Systolic blood pressure, mmHg 133 ± 20
Diastolic blood pressure, mmHg 78 ± 10
BMI, kg/m2 24.7 ± 3.8
Heart rate, beats per minute 65 ± 13
CMR data
LV ejection fraction, % 66 ± 4
LV end diastolic volume, ml 155 ± 31
LV EDV indexed BSA, ml/m2 82 ± 14
LV end systolic volume, ml 52 ± 13
LV stroke volume, ml 103 ± 21
Cardiac output, L/min 6.5 ± 1.4
Values are mean ± standard deviations
BMI indicates Body mass index, CMR Cardiovascular magnetic resonance, LV
Left ventricle, EDV End diastolic volume, BSA Body surface area
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= 0.509, P = 0.009, retained inflow r = 0.424, P = 0.035,
delayed ejection flow r = 0.500, P = 0.009 and residual
volume r = 0.414, P = 0.04).
Discussion
This study presents results from the largest cohort to date
of healthy subjects for the quantification of LV flow compo-
nents’ volume and KE values. The baseline data are in
agreement with those from previous studies [3, 5, 7] with
direct flow being the largest flow component, as a percent-
age of the EDV. The direct flow is also the component that
possesses the highest kinetic energy value at ED. We found
the retained inflow and delayed ejection flow components
to be very similar as a proportion of the EDV, which pro-
vides a reassuring data quality control as they are inter-
related components. These components are inter-related as
much of the incoming retained inflow is ejected during the
subsequent cardiac cycle as the delayed ejection flow,
furthermore the volumes must be the same to preserve the
cardiac volume. We successfully conducted scan-rescan
data acquisitions to assess for repeatability and post-
processing variability as well as interval scans to assess for
the additional effect of physiological variability.
Repeatability of data acquisition and post-processing
To our knowledge this is the first study to report 4D flow
data from scan-rescan data acquisitions, where the aim
was to attempt to quantify the magnitude of variation that
is due to inherent sources of error in the data acquisition,
post-processing and analysis. The scan-rescan repeatabil-
ity was good for the flow components as a proportion of
the EDV and slightly more variable for the KE values. The
coefficients of variation we found for our flow component
Fig. 2 a Bland-Altman plots for scan-rescan data; flow components as percentage EDV (top row) and kinetic energy at end diastole (bottom row). Dotted
lines represent 95% confidence intervals, unbroken line represents bias. b Bland-Altman plots for interval scan data; flow components as percentage EDV
(top row) and kinetic energy at end diastole (bottom row). Dotted lines represent 95% confidence intervals, unbroken line represents bias
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volumes were of a similar magnitude to those found in LV
volumes calculated by cine CMR for conventional LV
parameters including LV EDV, LV ESV and LV EF that
found coefficients of variation between 4.1–10.3% [16].
Analysis of the influence of the post-processing steps
including LV segmentation and selection of the appro-
priate time frame for ED and ES was assessed via the
intra and inter-observer variability. The coefficients of
variation for the flow component proportions were very
similar between the intra and inter-observer variability
results. These results are in agreement with previous
studies assessing intra and inter-observer variability for
cine CMR LV volumes [16, 17] and a study assessing
flow component proportions that showed no difference
in the group means and standard deviation [3]. These
findings are expected; the main influence the operator
has upon the post processing of the data is the contour-
ing of the short axis ventricular images at ED and ES,
which is then used to create the mask for analysis of the
flow data. Both investigators undertaking analysis in this
study are experienced at placing LV contours and were
trained in the same CMR unit so will have similar
contouring styles. The intra-observer coefficient of vari-
ation for the flow components as a proportion of the
EDV was similar to that obtained for the scan-rescan
data analysis suggesting that much of the variability in
the results will be from the data analysis steps and not
the data acquisition itself.
Influence of physiological variability upon interval scans
The flow components as a percentage of the EDV and
the KE of each component at ED were not significantly
different between visit 1 and 2 across the group, however
on a per participant basis there was greater variability
between visit 1 and 2.. As expected the coefficients of
variation were higher for all measured parameters for
the 2 scans performed at an interval compared to the 2
scans performed in the same study visit. The results
from the scan-rescan data acquisitions provide an esti-
mation of the variability in 4D flow data acquisition,
post-processing and analysis. The additional variability
seen with the interval scans over scan-rescan suggests
that as well as the differences in data acquisition, post
processing and analysis there are additional influencing
factors. We hypothesised that the increased variability
was most likely due to a degree of normal physiological
variability. We found that the change in heart rate re-
corded between the 2 interval scans correlated modestly
to the changes seen in the flow components as a propor-
tion of the EDV. This is an interesting finding and may
be explained by the longstanding physiological observa-
tion that changes in heart rate predominantly affect the
diastolic phase of the cardiac cycle, as the systolic phase
is of a relatively fixed duration [18]. Hence, it may be
that as the heart rate changes the proportions of the
flow components alter to adapt to the new length of the
diastolic period, whilst still maintaining an efficient sys-
tolic ejection phase. This may be an important physio-
logical adaptation for exercise, which would be interesting
to assess in future studies, including in disease states.
However, the correlations with heart rate alone were only
modest, suggesting further additional physiological factors
such as fluid status, vascular tone and hormonal influ-
ences may be implicated in the variability seen for interval
data acquisitions.
Individual flow components
Direct flow was consistently the largest component with
the highest possession of energy at ED; it was also the
least variable of the four flow components in both com-
position and KE values. The direct flow represents the
blood that transits directly from the left atrium via the LV
cavity to be ejected into the aorta within the same cardiac
cycle. Previous studies have demonstrated that the direct
flow follows an efficient pathway to the LV outflow tract
with the shortest distance, more favourable angle and
Table 4 Repeatability of measurements comparing scan-rescan
and interval scans
Scan-rescan Interval scans
Observed
mean
difference
(95%
confidence
interval)
CoV Observed
mean
difference
(95%
confidence
interval)
CoV P value
between
CoV for
scan-rescan
and interval
scans
End diastolic
volume, ml
6.6 (−11.9 to 25.1) 4.6 1.1 (−19.2 to 21.4) 4.6 0.65
End systolic
volume, ml
1.4 (−7.3 to 10.2) 6.8 −1.0 (− 13.3 to 11.3) 9.5 0.11
Left ventricular
ejection fraction,
%
0.4 (−5.5 to 6.5) 3.0 1.1 (−5.2 to 7.3) 3.3 0.12
Heart rate, bpm 4.3 (−6.9 to 15.5) 7.6 1.7 (−11.7 to 15.1) 6.8 0.18
Volume ratios
Direct flow,
% EDV
−0.2 (−2.8 to 2.3) 2.5 −1.0 (−7.1 to 5.1) 6.2 0.10
Retained inflow,
% EDV
−0.5 (−4.1 to 3.0) 6.6 0.7 (−6.0 to 7.5) 16.1 0.04
Delayed ejection
flow, % EDV
0.6 (−3.9 to 5.0) 9.2 −0.6 (−7.2 to 6.0) 15.0 0.07
Residual volume,
% EDV
0.2 (−2.0 to 2.4) 3.0 0.9 (−5.4 to 7.2) 8.0 0.007
Kinetic energy
Direct flow KE
at ED, μJ/ml
0.4 (−2.8 to 3.7) 13.5 −0.01 (−4.2 to 4.2) 16.9 0.40
Retained inflow
KE at ED, μJ/ml
0.5 (−1.6 to 2.6) 13.8 0.03 (−3.5 to 3.5) 20.4 0.13
Delayed ejection
flow KE at ED,
μJ/ml
0.7 (−1.5 to 3.0) 17.7 0.6 (−2.5 to 3.8) 27.5 0.16
Residual volume
KE at ED, μJ/ml
0.06 (−0.5 to 0.6) 15.4 0.1 (−0.8 to 0.9) 29.0 0.23
CoV Coefficient of variation, EDV End diastolic volume, bpm Beats per minute
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increased linear momentum in comparison to the other
flow components [7]. This suggests that in a healthy heart
the percentage of blood pumped via the efficient shorter
pathway taken by the direct flow component is relatively
consistent; this may allow conservation of the KE of this
component, which may be important in reducing the add-
itional energy that is required for its ejection during
systole. The residual volume was the second most stable
component over time in terms of composition, but pos-
sessed the most variable amount of KE. The residual
volume is located at the periphery of the LV cavity, outlin-
ing the functional border of the chamber, providing a
fluid-fluid interface that interacts with the exchanging
blood flow [9]. The location and stability in terms of the
percentage of the residual volume could imply it is a static
component of the LV blood flow volume. However the
variability of the KE it possesses suggests it remains part
of the dynamic interactions that occur with the incoming
and outgoing cardiac blood flow within the LV cavity dur-
ing each cardiac cycle. This may be an important factor in
preventing blood stasis and thrombus formation within
the healthy heart.
The KE for the retained inflow component at ED was sig-
nificantly lower than that of the delayed ejection flow. This
finding is in keeping with the notion proposed by Bolger et
al. [5] that the retained inflow blood has to decelerate at the
end of diastole and then acquire additional kinetic energy
prior to ejection during a subsequent systole (as part of the
delayed ejection flow). Previous studies have demonstrated
a late diastolic boost in the KE of the delayed ejection flow,
which was presumed to result from transfer of energy from
the inflow components, so it may be that the KE is inter-
changed predominantly from the retained inflow to the de-
layed ejection flow. The amount of energy present within
the delayed ejection flow at ED was not significantly differ-
ent to the energy possessed by the direct flow; suggesting
that a threshold level of kinetic energy favours ejection of
blood from the LV during systole.
Clinical applications
The applicability of 4D flow to assess the severity of
cardiac disease has been previously demonstrated in
patients with clinically compensated mild heart failure
secondary to dilated cardiomyopathy [8] and ischaemic
cardiomyopathy [19]. The use of this technique in lon-
gitudinal clinical studies is now required to assess how
these parameters change over time in patients with
Fig. 3 Interval scan popoulation differences in the 4 LV flow components for the 25 participants: a As percentage of EDV at visit 1 and 2. b
Kinetic energy at end-diastole related to blood volume at visit 1 and 2
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heart disease and whether 4D flow parameters provide
additional information to current imaging techniques
in monitoring these patients.
Limitations
The 4D flow data acquisitions undertaken in this study
were conducted at rest. Given the relationship between
the change in heart rate and the flow components as a
percentage of the EDV it would be interesting to assess
whether these proportions vary to a greater degree in an
exercising heart. Blood flow within the heart is a dy-
namic process and 4D flow data is acquired over many
heart beats with the end data representing the blood
flow over an averaged cardiac cycle. In order to under-
stand further if haemodynamic changes during the data
acquisition influenced the final results continuous moni-
toring of heart rate and central blood pressure would be
needed. For these measurements to be reliable they
would need to be invasive which we felt would be too
high a burden for our participants. The findings pre-
sented here are from a single study site and although
they are in keeping with previous studies, future studies
comparing the same study participants at different sites
would provide additional validation of the 4D flow LV
flow components’ volume and KE profiles. The two
study groups (scan-rescan versus interval scan) consisted
of different participants. We cannot exclude an influence
of this upon the results seen, but as both groups had
normal cardiac function and similar flow parameters we
would expect any variability to be the same between
these two groups. Finally the participants enrolled in this
study were all healthy subjects and the reproducibility of
this technique in patients with cardiac disease remains
to be investigated. However it is unlikely that this tech-
nique will have less variability over time in patients with
heart disease than controls, so this data may still act as
an aid in assessing the significance of any changes in 4D
flow parameters seen with longitudinal studies.
Conclusions
This study provides an increased understanding of the
variability of blood flow within the healthy heart. LV flow
components’ relative volume and kinetic energy values are
repeatable and are stable within a population over time.
However, the variability of these measures in individuals
over time is greater than can be attributed to inherent
sources of error in the data acquisition, post processing
and analysis, suggesting that additional physiological
factors may influence the volume and KE profiles of the
flow components. The assessment of intra-cardiac blood
flow may become helpful in examining disease states and
quantification of the variability of the results from this
technique prior to this use is important.
Additional file
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